Sucralfate has a long track record as a well-tolerated ulcer medication, and clinical trials consistently show it heals duodenal and gastric ulcers at rates comparable to acid-suppressing drugs. Yet it works through a fundamentally different mechanism, forming a physical barrier over damaged tissue rather than reducing stomach acid. That distinction shapes nearly everything about its strengths, its limitations, and the situations where it shines or falls short compared to alternatives.
How Sucralfate Actually Works
Most acid-related medications work by dialing down the amount of acid your stomach produces. Sucralfate takes the opposite approach: it leaves acid production alone and instead shields the ulcer from further damage. When sucralfate reaches the acidic environment of the stomach, it forms a sticky, paste-like substance that binds preferentially to ulcerated or damaged tissue. This protective coating can persist for several hours, acting as a physical barrier between the wound and stomach acid, bile salts, and digestive enzymes.
The barrier effect is only part of the story. Research in rats has confirmed that sucralfate also stimulates the local production of prostaglandins, which are compounds that promote blood flow and mucus secretion in the stomach lining. Sucralfate also binds epidermal growth factor and concentrates it at the ulcer site, which may accelerate tissue repair.1PubMed. Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats These additional biological effects help explain why sucralfate performs as well as it does despite not touching acid secretion at all.
How Well It Heals Ulcers
The central question most people have is straightforward: does sucralfate actually work? The clinical evidence is clear that it does, and it has been tested extensively against acid-reducing drugs. A comprehensive review of controlled trials found that sucralfate at one gram four times daily increased the rate of duodenal and gastric ulcer healing over four to eight weeks, and that trials comparing it head-to-head with cimetidine (an older acid blocker) showed no significant difference in effectiveness between the two.2PubMed. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease
One double-blind randomized trial put specific numbers on this. After four weeks, 80% of patients taking sucralfate had their duodenal ulcer completely healed, compared with about 76% in the cimetidine group. By eight weeks, the rates climbed to 90% and 86%, respectively. The differences were not statistically significant, and symptom relief and side effects were also comparable between the two drugs.3PubMed. Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial In other words, sucralfate healed ulcers just as effectively as a mainstream acid suppressor.
It is worth noting that these comparisons were made against cimetidine, which is an earlier-generation acid blocker. Modern proton pump inhibitors like omeprazole tend to produce somewhat faster healing, and they became the go-to drugs for most ulcer patients starting in the 1990s. Sucralfate fell out of the spotlight not because it failed but because newer options were more convenient to take. That said, its different mechanism of action means it still has distinct advantages in certain situations.
Stress Ulcer Prevention in Hospital Settings
One area where sucralfate’s unique mechanism has sparked genuine debate is in critically ill patients. People in intensive care units are at risk for stress ulcers, and doctors routinely prescribe medications to prevent them. The big question has been whether sucralfate, which doesn’t suppress acid, carries a lower risk of hospital-acquired pneumonia than acid-reducing drugs. The logic is that stomach acid acts as a natural defense against bacterial overgrowth. When you suppress acid with drugs like H2 receptor antagonists or proton pump inhibitors, bacteria can multiply more easily in the stomach and potentially migrate into the lungs.
The evidence supports this concern. A meta-analysis of randomized trials found that patients receiving sucralfate had a statistically significant lower risk of ICU-acquired pneumonia compared to those given H2 receptor antagonists, with roughly a 16% relative reduction in pneumonia risk.4PubMed. Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials An earlier meta-analysis reached a similar conclusion, finding that pneumonia was significantly more frequent in patients given H2 antagonists or antacids compared with those given sucralfate.5Critical Care Medicine. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: A meta-analysis on efficacy and pneumonia rate
Despite this apparent advantage, sucralfate is not the default choice in most ICUs today. Some larger trials have suggested that proton pump inhibitors provide somewhat better bleeding prevention, and the pneumonia advantage of sucralfate has been debated as study methodologies have evolved. Still, the pneumonia data remain a legitimate reason some intensivists consider sucralfate, particularly in patients already at high risk for respiratory infections.
Side Effects and the Aluminum Question
Sucralfate has a reputation for being gentle, and for most people it is. The most common side effect by far is constipation, which makes sense given that the drug contains aluminum. Other complaints like nausea, dry mouth, or an unpleasant taste are reported occasionally but tend to be mild. Compared with many gastrointestinal drugs, sucralfate’s side-effect profile in people with normal kidney function is genuinely modest.
The picture changes if your kidneys don’t work well. Sucralfate contains aluminum, and while the amount absorbed into the bloodstream is small, it is not zero. In people with chronic renal failure, the body cannot efficiently clear that aluminum, and it accumulates. Research has shown that serum aluminum levels rise within two days of starting sucralfate in patients with kidney disease and remain elevated throughout treatment. The levels in those patients were meaningfully higher than in people with normal kidney function.6The American Journal of Medicine. Aluminum absorption and excretion following sucralfate therapy in chronic renal insufficiency Over time, accumulated aluminum can cause problems ranging from bone disease to neurological symptoms.
For this reason, long courses of sucralfate should be used cautiously or avoided entirely in people with compromised kidney function.7PubMed. Use of sucralfate in renal failure If you have kidney disease and a doctor prescribes sucralfate, it is reasonable to ask whether the expected duration of treatment poses a risk, and whether an alternative would be safer for you.
Drug Interactions Worth Knowing About
Because sucralfate forms that sticky coating in the stomach, it can physically bind to other medications and prevent them from being absorbed properly. This is probably the most important practical consideration for anyone taking sucralfate alongside other drugs. The interaction is not a subtle biochemical effect; it is simply the medication getting trapped in the sucralfate layer and passing through your system without ever reaching your bloodstream.
Thyroid medication is the most well-documented example. Researchers found that taking sucralfate at the same time as levothyroxine significantly reduced thyroid hormone absorption and delayed peak absorption by about two hours.8PubMed. Sucralfate causes malabsorption of L-thyroxine For someone relying on precise thyroid hormone dosing, that kind of interference can throw off their levels and symptoms. The same type of binding interaction has been reported with fluoroquinolone antibiotics, certain antifungal medications, phenytoin, and some other drugs.
The standard workaround is simple: take other medications at least two hours before or after sucralfate. This gives the other drug time to be absorbed before sucralfate’s barrier forms, or allows the barrier to clear before the other drug arrives. If you are on multiple medications and sucralfate is added to the mix, mapping out the timing with a pharmacist is a genuinely useful step. The four-times-daily dosing schedule of sucralfate can make this tricky, especially when other medications also have specific timing requirements.
The Dosing Burden Problem
Speaking of that schedule, the traditional sucralfate regimen, one gram four times a day taken on an empty stomach, is one of the drug’s biggest practical drawbacks. You are supposed to take it an hour before each meal and at bedtime, which means structuring a significant portion of your day around pills. For a medication course lasting four to eight weeks, that adds up to a real lifestyle nuisance. Miss doses or take them with food, and the drug may not work as well since it needs stomach acid to activate and an empty stomach to bind properly to the ulcer.
Some research has explored whether twice-daily dosing at a higher individual dose could work just as well while easing the burden. In practice, many clinicians have shifted toward less frequent dosing for selected patients, though the original four-times-daily regimen remains the most studied and the one referenced in most prescribing guidelines. If adherence is a struggle, this is a conversation worth having with your prescriber. A medication that works well in theory but sits untaken on the counter does not help anyone.
Use in Children
Sucralfate is not only an adult medication. It has been studied in children with peptic esophagitis, a condition where stomach acid damages the lining of the esophagus. In a trial of 75 children diagnosed endoscopically with esophagitis, patients were treated with either cimetidine, sucralfate tablets, or sucralfate suspension. The results showed no significant differences between the three groups, leading the researchers to conclude that sucralfate is a useful drug for treating peptic esophagitis in children.9The American Journal of Medicine. Efficacy of sucralfate in comparison with cimetidine in the treatment of peptic esophagitis in children
The suspension form is particularly relevant for younger children who can’t swallow tablets. It also allows more flexible dosing. That said, pediatric use of sucralfate is less common today than it once was, largely because proton pump inhibitors have become available in pediatric formulations. Sucralfate remains a reasonable option, though, particularly when acid suppression is not desirable or when a child has not tolerated other medications.
Radiation Proctitis and Other Off-Label Uses
Some of the most interesting modern uses of sucralfate have nothing to do with stomach ulcers. Because the drug works by coating and protecting damaged tissue, clinicians have experimented with applying it directly to wounds and inflamed surfaces throughout the body.
Radiation proctitis, a painful condition in which radiation therapy damages the lining of the rectum, is one example. A study tested sucralfate paste enema in patients with hemorrhagic radiation proctitis and found that about 73% showed clinical improvement, with roughly a third achieving complete resolution of all symptoms.10PubMed. Sucralfate paste enema: a new method of topical treatment for haemorrhagic radiation proctitis No patients deteriorated during treatment. For a condition that can be difficult to manage and significantly impacts quality of life, these results are meaningful even in a relatively small study.
Topical sucralfate has also been explored for various types of epithelial wounds, including skin ulcers, inflammatory dermatitis, mucositis (the painful mouth sores that often develop during chemotherapy), and burn wounds.11PubMed. Topical use of sucralfate in epithelial wound healing: clinical evidences and molecular mechanisms of action The underlying logic is the same: sucralfate forms a protective layer, concentrates growth factors, and promotes tissue repair regardless of whether the surface is gastric lining or skin.
Sucralfate for Burns
The burn wound application deserves its own discussion because the evidence has grown more robust in recent years. A year-long randomized controlled trial compared topical sucralfate dressing with silver sulfadiazine, which is the conventional standard for burn care, in the management of second-degree superficial burns. Sucralfate produced earlier granulation tissue and accelerated overall wound healing compared to silver sulfadiazine, while the antimicrobial effect was comparable between the two treatments.12PubMed Central. Efficacy of topical sucralfate versus silver sulfadiazine in the management of burns: A 1-year randomized controlled trial
A systematic review looking across multiple studies reinforced these findings, concluding that topical sucralfate showed a beneficial effect on burn wounds including better wound healing rates, decreased infection rates, and enhanced epithelialization and granulation, with no local or systemic adverse reactions reported.13Open Access Macedonian Journal of Medical Sciences. A Systematic Review: Topical Sucralfate for Burn Wound This is a promising area, particularly in settings where silver sulfadiazine’s cost or availability is a concern. Sucralfate is inexpensive and widely available, which makes it an appealing alternative for burn care in resource-limited contexts.
Next-Generation Formulations
Researchers are also looking beyond the traditional tablet and suspension forms. One recent development uses sucralfate as the backbone for a nanoparticle delivery system. The idea is that sucralfate’s natural ability to coat the gastrointestinal tract can be harnessed to deliver therapeutic nanoparticles along the entire length of the gut. An oral formulation has been developed that transforms into a paste-like coacervate upon contact with intestinal fluid, uniformly coating the full gastrointestinal tract within about six hours and clearing through fecal transit by twelve hours.14PubMed. Orally Administered Nanoparticle Coacervate for Therapeutic Coating of Full Gastrointestinal Tract
This approach is still in the early stages, but it opens up possibilities for delivering drugs to areas of the intestine that are difficult to target with conventional pills. Conditions like inflammatory bowel disease, where damage can occur anywhere along the gut, might eventually benefit from sucralfate-based delivery platforms that deposit medication directly where it is needed. The fact that sucralfate already has a long safety record in humans makes it an attractive starting material for these kinds of innovations.
Who Should Think Twice
Sucralfate works well for many people, but a few groups need to be more careful. As discussed, anyone with kidney impairment faces the risk of aluminum accumulation and should either avoid sucralfate or use it only under close monitoring for a short course. People on multiple medications, particularly thyroid hormones or fluoroquinolone antibiotics, need to plan their dosing schedule carefully to avoid absorption problems.
Pregnancy is another area that warrants caution. Sucralfate is often described as relatively safe in pregnancy because its systemic absorption is minimal. However, animal research has raised questions worth noting. A study in pregnant mice found that sucralfate given alongside a dietary protein supported allergic sensitization in the mothers and promoted a particular type of immune bias in their offspring.15PubMed Central. Anti-ulcer treatment during pregnancy induces food allergy in mouse mothers and a Th2-bias in their offspring This is animal data and does not directly translate to humans, but it does suggest that the interaction between gut-protective drugs and the immune system during pregnancy is more complex than “minimal absorption means minimal concern.” Any decision about sucralfate during pregnancy should involve weighing the potential benefits against the available evidence and discussing it with a healthcare provider.
People who struggle with constipation should also know that sucralfate can make it worse. This is usually manageable with dietary adjustments or a mild stool softener, but for someone already dealing with chronic constipation from other medications or conditions, adding sucralfate may tip the balance in an uncomfortable direction.
Veterinary Use
Sucralfate has a parallel life in veterinary medicine, where it is widely used in dogs and cats for gastrointestinal ulceration and erosion. The veterinary internal medicine community has published consensus guidance on when gastrointestinal protectants, including sucralfate, are rationally indicated in small animals.16Journal of Veterinary Internal Medicine. ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats The drug works the same way in animals as in humans, forming a protective barrier over ulcerated tissue. Pet owners sometimes encounter sucralfate when their dog or cat is prescribed it after surgery, while taking anti-inflammatory medications, or for unexplained GI bleeding. The suspension form is easier to administer to animals and is usually given on an empty stomach, just as in humans. If your vet prescribes sucralfate for your pet, the same drug interaction concerns apply: separate it from other medications by at least an hour or two to avoid absorption problems.